Plain-English translation of ·
This study is trying to understand whether how much you move in the first few weeks after starting a biologic medication can predict how well that treatment will work for your rheumatoid arthritis. Researchers will give you a device to wear that tracks your daily physical activity, and they'll follow you over time to see if people who become more active early on also experience better long-term results from the medication.
Many people with rheumatoid arthritis still struggle with pain, fatigue, and reduced ability to do daily activities even after starting strong anti-inflammatory treatments. This study hopes to find an early warning sign—improved movement—that could help doctors predict which patients will benefit most from the medication, so they can better tailor treatment plans and help people get back to their normal lives.
You likely qualify if…
You likely don't qualify if…
You would wear a small accelerometer device (similar to a fitness tracker) that measures your movement throughout your daily life. You'll also complete questionnaires about your symptoms and how you're feeling. The study team will track your physical activity and check in on how the biologic medication is working for you over time to see if early improvements in how much you move can predict your long-term treatment success.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Denmark